241 related articles for article (PubMed ID: 28461248)
1. Simultaneous triple therapy for the treatment of status epilepticus.
Niquet J; Baldwin R; Norman K; Suchomelova L; Lumley L; Wasterlain CG
Neurobiol Dis; 2017 Aug; 104():41-49. PubMed ID: 28461248
[TBL] [Abstract][Full Text] [Related]
2. Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits.
Niquet J; Baldwin R; Norman K; Suchomelova L; Lumley L; Wasterlain CG
Epilepsia; 2016 Sep; 57(9):1406-15. PubMed ID: 27500978
[TBL] [Abstract][Full Text] [Related]
3. Early polytherapy for benzodiazepine-refractory status epilepticus.
Niquet J; Lumley L; Baldwin R; Rossetti F; Schultz M; de Araujo Furtado M; Suchomelova L; Naylor D; Franco-Estrada I; Wasterlain CG
Epilepsy Behav; 2019 Dec; 101(Pt B):106367. PubMed ID: 31636007
[TBL] [Abstract][Full Text] [Related]
4. Rational polytherapy in the treatment of cholinergic seizures.
Niquet J; Lumley L; Baldwin R; Rossetti F; Suchomelova L; Naylor D; Estrada IBF; Schultz M; Furtado MA; Wasterlain CG
Neurobiol Dis; 2020 Jan; 133():104537. PubMed ID: 31454548
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Lacosamide and Rufinamide as Adjuncts to Midazolam-Ketamine Treatment Against Cholinergic-Induced Status Epilepticus in Rats.
Lumley LA; Nguyen DA; de Araujo Furtado M; Niquet J; Linz EO; Schultz CR; Stone MF; Wasterlain CG
J Pharmacol Exp Ther; 2024 Jan; 388(2):347-357. PubMed ID: 37977809
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors.
Lumley L; Niquet J; Marrero-Rosado B; Schultz M; Rossetti F; de Araujo Furtado M; Wasterlain C
Neuropharmacology; 2021 Mar; 185():108444. PubMed ID: 33359073
[TBL] [Abstract][Full Text] [Related]
7. Treatment of experimental status epilepticus with synergistic drug combinations.
Niquet J; Baldwin R; Suchomelova L; Lumley L; Eavey R; Wasterlain CG
Epilepsia; 2017 Apr; 58(4):e49-e53. PubMed ID: 28225161
[TBL] [Abstract][Full Text] [Related]
8. Diazepam Monotherapy or Diazepam-Ketamine Dual Therapy at Different Time Points Terminates Seizures and Reduces Mortality in a Status Epilepticus Animal Model.
Zhou R; Wang Y; Cao X; Li Z; Yu J
Med Sci Monit; 2021 Dec; 27():e934043. PubMed ID: 34866132
[TBL] [Abstract][Full Text] [Related]
9. Combination of antiseizure medications phenobarbital, ketamine, and midazolam reduces soman-induced epileptogenesis and brain pathology in rats.
Lumley LA; Marrero-Rosado B; Rossetti F; Schultz CR; Stone MF; Niquet J; Wasterlain CG
Epilepsia Open; 2021 Dec; 6(4):757-769. PubMed ID: 34657398
[TBL] [Abstract][Full Text] [Related]
10. Ketamine as adjunct to midazolam treatment following soman-induced status epilepticus reduces seizure severity, epileptogenesis, and brain pathology in plasma carboxylesterase knockout mice.
Marrero-Rosado BM; de Araujo Furtado M; Kundrick ER; Walker KA; Stone MF; Schultz CR; Nguyen DA; Lumley LA
Epilepsy Behav; 2020 Oct; 111():107229. PubMed ID: 32575012
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Midazolam-Ketamine-Allopregnanolone Combination Therapy against Cholinergic-Induced Status Epilepticus in Rats.
Nguyen DA; Stone MF; Schultz CR; de Araujo Furtado M; Niquet J; Wasterlain CG; Lumley LA
J Pharmacol Exp Ther; 2024 Jan; 388(2):376-385. PubMed ID: 37770198
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
[TBL] [Abstract][Full Text] [Related]
13. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
Löscher W
Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944
[TBL] [Abstract][Full Text] [Related]
14. Treatment with valproate after status epilepticus: effect on neuronal damage, epileptogenesis, and behavioral alterations in rats.
Brandt C; Gastens AM; Sun Mz; Hausknecht M; Löscher W
Neuropharmacology; 2006 Sep; 51(4):789-804. PubMed ID: 16806297
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of a combined anti-seizure treatment against cholinergic established status epilepticus following a sarin nerve agent insult in rats.
Lazar S; Neufeld-Cohen A; Egoz I; Baranes S; Gez R; Glick P; Cohen M; Gutman H; Chapman S; Gore A
Toxicol Appl Pharmacol; 2024 Mar; 484():116870. PubMed ID: 38395364
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat.
Gore A; Neufeld-Cohen A; Egoz I; Baranes S; Gez R; Efrati R; David T; Dekel Jaoui H; Yampolsky M; Grauer E; Chapman S; Lazar S
Toxicol Appl Pharmacol; 2021 May; 419():115519. PubMed ID: 33823148
[TBL] [Abstract][Full Text] [Related]
17. Addition of ketamine to standard-of-care countermeasures for acute organophosphate poisoning improves neurobiological outcomes.
Lewine JD; Weber W; Gigliotti A; McDonald JD; Doyle-Eisele M; Bangera N; Paulson K; Magcalas C; Hamilton DA; Garcia E; Raulli R; Laney J
Neurotoxicology; 2018 Dec; 69():37-46. PubMed ID: 30172622
[TBL] [Abstract][Full Text] [Related]
18. Resistance to antiepileptic drugs and expression of P-glycoprotein in two rat models of status epilepticus.
Bankstahl JP; Löscher W
Epilepsy Res; 2008 Nov; 82(1):70-85. PubMed ID: 18760905
[TBL] [Abstract][Full Text] [Related]
19. Management of generalised convulsive status epilepticus (SE): A prospective randomised controlled study of combined treatment with intravenous lorazepam with either phenytoin, sodium valproate or levetiracetam--Pilot study.
Mundlamuri RC; Sinha S; Subbakrishna DK; Prathyusha PV; Nagappa M; Bindu PS; Taly AB; Umamaheswara Rao GS; Satishchandra P
Epilepsy Res; 2015 Aug; 114():52-8. PubMed ID: 26088885
[TBL] [Abstract][Full Text] [Related]
20. Phosphatase inhibition prevents the activity-dependent trafficking of GABAA receptors during status epilepticus in the young animal.
Joshi S; Rajasekaran K; Hawk KM; Brar J; Ross BM; Tran CA; Chester SJ; Goodkin HP
Epilepsia; 2015 Sep; 56(9):1355-65. PubMed ID: 26248944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
